1-4 of 4
Amado Karduss, MD
Close
Sort by
Journal Articles

Results from the International, Multi-Center, Retrospective B-Holistic Study: Describing Treatment Pathways and Outcomes for Classical Hodgkin Lymphoma

Burhan Ferhanoglu, MD, Tae Min Kim, MD PhD, Amado Karduss, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Gayane Tumyan, Mubarak Al Mansour, Marta Zerga, MD, Yuqin Song, MD PhD, Silvia Rivas-Vera, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, Su-Peng Yeh, MD, Arif Abdillah, MD, Zhongwen Huang, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg, MBBS PhDFRACP FRCPA
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–34.
https://doi.org/10.1182/blood-2020-134885
Published: 2020
Journal Articles

Brentuximab Vedotin As Consolidation Therapy Post Hematopoietic Stem Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma: A Real World Analysis of the Colombian Experience

Bonell Patiño, MD, Cristina Acon-Solano, MD, Mario Pereira, MD, Leonardo Enciso-Olivera, MD, Diana Otero-de la Hoz, MD, Humberto Martínez Cordero, MD, Paola Spirko, MD, Julio Solano-Vega, MD, Mónica Arévalo-Zambrano, MD, Ulrike Heider, MD, Alejandro Ruiz-Patiño, MD, Claudia Lucia Sossa, MD, Angela María Peña, MD, Claudia Marcela Chalela, MD, Amado Karduss, MD, Guillermo León-Basantes, MD, Virginia Abello, MD, Daniel Lorenzo Espinosa, MD, Paola Guerrero, MD, Alvaro Guerrero, MD, Juan Manuel Herrera, MD, Monica Osuna, MD, Ivan Perdomo, MD, Carmen Rosales, MD, Paola Omaña, MD, Natalia Villarroya, MD, Víctor Rodriguez-Sanjuan, MD, Jose Sandoval-Sus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5275.
https://doi.org/10.1182/blood-2019-129295
Published: 2019
Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg
Journal: Blood
Blood (2018) 132 (Supplement 1): 2917.
https://doi.org/10.1182/blood-2018-99-111146
Published: 2018
Journal Articles

The Early Referral for Reduced-Intensity Stem Cell Transplantation in Patients with Ph1 (+) Chronic Myelogenous Leukemia in Chronic Phase in the Imatinib Era: Results of the Latin American Cooperative Oncohematology Group (LACOHG) Prospective, Multicenter Study.

Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP(Glasg), David Gomez-Almaguer, MD, Amelia Morales-Toquero, MD, Cesar H. Gutierrez-Aguirre, Jorge Vela-Ojeda, Miriam A. Garcia-Ruiz-Esparza, MD, Carlos Manzano, MD, Amado Karduss, MD, Abraham Sumoza, MD, Carmino de-Souza, MD, Eliana Miranda, MD, Sergio Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 4838.
https://doi.org/10.1182/blood.V106.11.4838.4838
Published: 2005